339 related articles for article (PubMed ID: 11122977)
1. Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.
Kochan LD; Qureshi AI; Fallon BA
Curr Psychiatry Rep; 2000 Aug; 2(4):327-34. PubMed ID: 11122977
[TBL] [Abstract][Full Text] [Related]
2. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
3. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
5. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
7. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments.
Berlin HA; Hamilton H; Hollander E
Mt Sinai J Med; 2008; 75(3):174-203. PubMed ID: 18704978
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological guidelines for the treatment of refractory patients with obsessive-compulsive disorder].
Toro-Martínez E
Vertex; 2005; 16(64):442-5. PubMed ID: 16314898
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.
Lafleur DL; Pittenger C; Kelmendi B; Gardner T; Wasylink S; Malison RT; Sanacora G; Krystal JH; Coric V
Psychopharmacology (Berl); 2006 Jan; 184(2):254-6. PubMed ID: 16374600
[TBL] [Abstract][Full Text] [Related]
10. Obsessive-complusive disorder: pharmacological treatment.
Thomsen PH
Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I76-84. PubMed ID: 11140782
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
[TBL] [Abstract][Full Text] [Related]
12. Commonly asked questions in the treatment of obsessive-compulsive disorder.
Arumugham SS; Reddy YC
Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment Of OCD?
de Haan E
J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):383; author reply 383-4. PubMed ID: 16601639
[No Abstract] [Full Text] [Related]
14. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
Kordon A; Zurowski B; Wahl K; Hohagen F
Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636
[TBL] [Abstract][Full Text] [Related]
15. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
[TBL] [Abstract][Full Text] [Related]
16. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder.
Goddard AW; Shekhar A; Whiteman AF; McDougle CJ
Drug Discov Today; 2008 Apr; 13(7-8):325-32. PubMed ID: 18405845
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
[TBL] [Abstract][Full Text] [Related]
18. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis.
Öst LG; Riise EN; Wergeland GJ; Hansen B; Kvale G
J Anxiety Disord; 2016 Oct; 43():58-69. PubMed ID: 27632568
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies for chronic and refractory obsessive-compulsive disorder.
Rasmussen SA; Eisen JL
J Clin Psychiatry; 1997; 58 Suppl 13():9-13. PubMed ID: 9402914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]